Global Radiation Therapy Devices Market Size By Type (External Beam Radiation Therapy, Internal Beam RadiOthersapy), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Radiation Therapy Devices Market was valued at USD 5.1 billion in 2023 and is projected to reach USD 8.6 billion by 2031, growing at a CAGR of 6.5% during the forecast period from 2023 to 2031. The growth of this market is primarily driven by the increasing incidence of cancer globally, technological advancements in radiotherapy equipment, and the rising demand for non-invasive cancer treatments. Radiation therapy remains a cornerstone in oncological treatment regimens, with innovations such as image-guided radiotherapy (IGRT), stereotactic body radiation therapy (SBRT), and proton beam therapy significantly enhancing treatment precision and outcomes.

Drivers:

1. Rising Global Cancer Incidence:

The steady rise in cancer prevalence worldwide, particularly in aging populations, is fueling demand for advanced radiotherapy solutions. As more healthcare systems prioritize early detection and treatment, the use of radiation therapy devices is becoming increasingly mainstream.

2. Technological Advancements in Radiotherapy:

Ongoing innovations, including adaptive radiotherapy, artificial intelligence-based planning, and integration with imaging technologies (CT, MRI), have greatly enhanced the precision, safety, and effectiveness of radiation therapy, accelerating adoption.

3. Shift Toward Outpatient Oncology Centers:

There is a growing trend toward decentralized oncology treatment, with standalone outpatient radiotherapy centers gaining popularity due to convenience and cost efficiency. This shift is expanding the market potential for compact, high-performance radiotherapy systems.

Restraints:

1. High Capital Investment and Maintenance Costs:

Radiation therapy devices involve substantial initial and maintenance expenditures, which can be a deterrent for smaller healthcare providers and facilities in low-income regions.

2. Complex Operational Requirements:

Effective use of advanced radiotherapy devices requires trained professionals and infrastructure support, which may be lacking in several emerging economies, limiting accessibility.

Opportunity:

1. Emerging Markets and Healthcare Infrastructure Expansion:

Rapid improvements in healthcare infrastructure across countries in Asia-Pacific, Latin America, and the Middle East present untapped opportunities for market players. Government initiatives to improve cancer care are expected to boost adoption.

2. Growing Demand for Personalized and Targeted Therapy:

Increasing focus on precision medicine is driving interest in personalized radiotherapy approaches, leading to greater demand for devices that enable customized treatment planning and delivery.

Market by System Type Insights:

The External Beam Radiation Therapy (EBRT) segment accounted for the largest market share in 2023, driven by widespread adoption of technologies like linear accelerators (LINACs) and proton beam therapy. This segment is expected to maintain dominance due to continuous upgrades in targeting capabilities and integration with imaging tools. Conversely, the Brachytherapy Devices segment is witnessing moderate growth, especially in gynecological and prostate cancer treatments, owing to its localized therapeutic benefits.

Market by End-use Insights:

In 2023, the Hospitals segment emerged as the largest revenue contributor, accounting for over 55% of the market share. Hospitals remain the primary end-users of radiotherapy devices due to their comprehensive cancer treatment capabilities. Meanwhile, Radiation Therapy Centers are expected to grow rapidly during the forecast period due to increased demand for specialized care and outpatient services.

Market by Regional Insights:

North America held the largest market share in 2023, supported by a high burden of cancer, advanced healthcare infrastructure, and strong reimbursement frameworks. Asia-Pacific is projected to witness the fastest growth, propelled by rising cancer cases, growing investments in healthcare technology, and increasing awareness about early cancer treatment in countries like China, India, and South Korea. Europe also holds a significant share, led by countries such as Germany, France, and the UK with mature oncology care systems.

Competitive Scenario:

Leading players in the Global Radiation Therapy Devices Market include Varian Medical Systems (Siemens Healthineers), Elekta AB, Accuray Incorporated, IBA Radiopharma Solutions, ViewRay Inc., Hitachi Ltd., Mevion Medical Systems, Canon Medical Systems Corporation, and Brainlab AG. These companies are engaged in continuous innovation, strategic partnerships, and global expansion initiatives. For instance:

In 2024, Varian launched an AI-enhanced radiotherapy planning system that significantly reduces treatment planning time.

Elekta AB announced a partnership in 2023 with a leading oncology group to deploy advanced adaptive therapy platforms across Europe.

Accuray Incorporated expanded its global footprint in 2025 with new installations of its CyberKnife® system in Asia-Pacific oncology centers.

Scope of Work – Global Radiation Therapy Devices Market

Key Market Developments:

April 2024: Varian announced FDA clearance for its FLASH radiotherapy platform, enabling ultra-high dose treatments in less than a second.

February 2023: Elekta introduced its next-generation MR-Linac system, combining high-definition imaging with adaptive radiotherapy.

June 2025: Mevion Medical Systems opened a new proton therapy R&D facility in Singapore to support Asia-Pacific growth.

FAQs:

1) What is the current market size of the Global Radiation Therapy Devices Market?

The market was valued at USD 5.1 billion in 2023.

2) What is the major growth driver of the Global Radiation Therapy Devices Market?

The primary driver is the increasing global incidence of cancer, alongside technological advancements in radiotherapy.

3) Which is the largest region during the forecast period in the Global Radiation Therapy Devices Market?

North America holds the largest market share due to advanced infrastructure and high adoption rates.

4) Which segment accounted for the largest market share in the Global Radiation Therapy Devices Market?

The External Beam Radiation Therapy (EBRT) segment held the largest share in 2023.

5) Who are the key market players in the Global Radiation Therapy Devices Market?

Key players include Varian (Siemens Healthineers), Elekta AB, Accuray, IBA, ViewRay, Hitachi, and Canon Medical Systems.